LeadInvent Pharma Inc. (LIP), is a nano-medicine company, developing gel formulation for enhancing brain cancer surgery. The company is HQ in the US (Philadelphia) with India R&D center in Kochi (Kerala). The cofounding and advisory team consists of Pharma and oncology professionals, brings over 350 man-year experience in drug development and pharma science. During brain cancer surgery, surgeons are not able to remove 100% tumor cells. The leftover tumor cells cause a relapse and patients lose their battle with the disease within 15 months from diagnosis. LeadInvent Pharma has created a unique gel (GBGel) that could be directly applied onto the tumor resected cavity. GBGel is engineered to kill cancer cells upon getting excited with a low power laser. A single dose of GBGel completely eliminates brain cancer in Wistar rats without recurrence. Preliminary toxicity studies indicate that GBGel is well tolerated with no observed side-effects at the treatment dose.